Review Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Sign: In combination with chemotherapy, for that procedure of adult patients with locally recurrent unresectable or metastatic triple-adverse breast cancer that have not acquired prior chemotherapy for metastatic ailment and whose tumours Specific programmed mobile Dying-ligand one (merged beneficial score ≥ 10) as b... https://friedrichc467qop8.wikicorrespondence.com/user